New IVI Member Spotlight Series
We, at the Innovation and Value Initiative, are deeply appreciative and excited about the growing number of members who share our commitment to advancing the science of value assessment. As part of our Value Source Blog, we are introducing our Member Spotlight series, where we talk with IVI members about the future of value assessment […]
Second Webinar in the ISPOR-IVI Series Explores Whether Value Assessments are Up to the Task in the Age of COVID-19
The second part of a five-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to task or in need of improvement for the pandemic era. Moderated by Lou Garrison, PhD (University […]
IVI and the University of Maryland Pharmacy School’s PAVE Center Partner on Patient-Centered Value Assessment
In an article in The Patient, IVI and the Patient-Driven Values in Healthcare Evaluation (PAVE) Center at the University of Maryland School of Pharmacy describe how they develop methods and models that make patient-centered value assessment both scientifically feasible and relevant to real-world decisions across the range of stakeholders. Read the full article here.
Jennifer Bright Discusses Her Journey and How to Improve Value Assessment
In an interview with Dr. William Seeds in Authority Magazine, Jennifer Bright talks about her own journey to IVI, what drives her to improve value assessment, and why collaboration is paramount for success. Read the full interview here.
The Promise of MCDA to Improve Equity in Value Assessment
In a commentary in AJMC, IVI examines how multi-criteria decision analysis has the potential to better understand and assess value for innovative cell and gene therapies which are transforming the lives of patients living with serious diseases. Read the full article here.
Can Depression Help Employers Improve Their Value Assessment Methods?
IVI’s Jennifer Bright and Mike Thompson of the National Alliance for Healthcare Purchasers share how employers can use depression as a “test case” for thinking about how to improve the value assessment process, so that we can apply a “purchaser-patient” lens up front. Read the full article on Employers Benefit News here.
How IVI Puts Patients at the Center of Value Assessment
Central to IVI’s work is ensuring patient perspectives are included at the front of all value assessments. This short video explains why and how IVI incorporates lived experience in its modeling.
Value Assessment During the COVID-19 Pandemic
The COVID-19 pandemic is raising new questions about how we approach value assessment. As always, IVI urges experts to use transparency, real world data, and seek consensus. Sam Nussbaum, President of the IVI Board of Directors, shares his thoughts in a commentary in STAT. Read the full commentary here.
Why Accounting for Our Differences Matter in Assessing Drug Value
IVI’s Jennifer Bright and Amy Miller, former CEO of the Society for Women’s Health Research, explain why patient heterogeneity is crucial to consider in any value assessment method. Read the full article here.
Experts Address Gaps in Value Assessment
Previewing their panel discussion at ISPOR 2020, Lou Garrison and Leah Howard discuss what’s needed to address gaps on value assessment. View the short video clip here.